Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Error on the MGUS-Autoimmune Disease Association.

2.

Scientists develop scans that light up aggressive cancer tumors for better treatment

3.

Chemo causes lasting physical decline in breast cancer survivors

4.

How Do Younger People Fare With Stool Tests for CRC Screening?

5.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot